Clase 3 - betabloqueantes(? (07/05/26)

Pharmacology of Heart Failure: Key Pillars and Mechanisms

Introduction to Heart Failure Pharmacology

• The discussion begins with an overview of heart failure pharmacology, focusing on the first pillar known as ARNI (Angiotensin Receptor Neprilysin Inhibitor) which combines two mechanisms of action.

Understanding ARNI and Its Mechanism

• ARNI involves antagonists of angiotensin II receptors (ARA2), such as valsartan, combined with neprilysin inhibition, which hydrolyzes natriuretic peptides A, B, and C. This dual mechanism is crucial for effective treatment.

• The goal of using ARNI is not only to improve inotropism but also to address remodeling and neurohormonal symptoms associated with heart failure. This includes managing sympathetic nervous system activation and the renin-angiotensin-aldosterone system (RAAS).

Role of Beta Blockers in Heart Failure

• The second pillar consists of beta-blockers, which may seem counterintuitive since they reduce heart contractility; however, they are essential due to chronic sympathetic overstimulation in heart failure patients.

• Beta-blockers primarily block beta-1 receptors, leading to decreased oxygen consumption and arrhythmias while improving ventricular geometry over time. They also have anti-remodeling effects that enhance survival rates.

Types of Beta Blockers Used

• Four beta-blockers with strong evidence for efficacy in heart failure include bisoprolol, carvedilol, metoprolol, and nebivolol. Bisoprolol and metoprolol are cardioselective (second generation), while carvedilol and nebivolol also antagonize alpha-1 receptors promoting vasodilation.

• Initial dosing should be low due to potential worsening symptoms at the start; doses can be gradually increased every two weeks based on patient response. Common side effects include bradycardia and hypotension from these medications.

Importance of Mineralocorticoid Receptor Antagonists

• The third pillar involves mineralocorticoid receptor antagonists like spironolactone and eplerenone that help mitigate aldosterone's harmful effects by blocking its receptors in various tissues including myocardium and blood vessels. This reduces fibrosis and inflammation linked to cardiac remodeling processes.

• Aldosterone contributes significantly to myocardial stiffness through inflammatory pathways; thus inhibiting it helps prevent adverse structural changes within the heart muscle over time. Potential side effects include hyperkalemia and hormonal imbalances like gynecomastia or menstrual irregularities from spironolactone use.

SGLT2 Inhibitors: A New Approach

• The fourth pillar comprises SGLT2 inhibitors such as dapagliflozin and empagliflozin that promote diuresis by blocking glucose-sodium transport in proximal tubules; this leads to reduced congestion in heart failure patients while providing renal protection against hyperfiltration injury.

• These agents have shown rapid improvement in clinical outcomes for patients with heart failure by enhancing metabolic efficiency through better utilization of ketones by the myocardium while reducing inflammation levels overall during treatment periods. Potential side effects include genital infections due to glucosuria among others related to excessive diuresis like hypotension or rare cases of euglycemic ketoacidosis in diabetic patients.

Historical Context: Digoxin Use

• Historically significant drugs like digoxin were once central treatments for heart failure but are now considered secondary options due to their narrow therapeutic index; they increase intracellular calcium leading to improved contractility but do not enhance survival rates compared with newer therapies discussed earlier.

Digoxin remains useful when symptoms persist despite optimal therapy or when controlling ventricular rate during atrial fibrillation episodes is necessary.

Potential risks involve toxicity especially if renal function declines or dosage adjustments aren't made appropriately based on individual patient needs.

Conclusion: Modern Treatment Paradigms

• Current guidelines emphasize a multi-faceted approach utilizing four key pillars—ARNI therapy alongside beta-blockers, mineralocorticoid receptor antagonists, plus SGLT2 inhibitors—to effectively manage chronic heart failure rather than relying solely on older agents like digoxin which lack mortality benefits.

Understanding these evolving paradigms will aid healthcare professionals in delivering comprehensive care tailored towards improving both quality-of-life metrics along with long-term prognostic outcomes for affected individuals suffering from this complex condition.

Understanding Hypertension and Heart Failure

Key Concepts in Pathophysiology

• The speaker emphasizes the importance of understanding the pathophysiology of both hypertension and heart failure for effective treatment.

• A recommendation is made to consult bibliographic resources for a deeper comprehension of these conditions.

Clarification on Practical Work

• A student, Lautaro, asks about a specific requirement (point five) related to their practical work involving medication.

• The speaker suggests that this question should be directed to Dr. Gerbán, indicating uncertainty about the details of the assignment.

Therapeutic Application Insights

• The speaker stresses the need for careful consideration when applying therapeutic reasoning, particularly in cases of arterial hypertension. Parameters that are out of balance should guide medication choices like beta-blockers or thiazide diuretics.

• It’s important to relate mechanisms of action with side effects (RAM), integrating knowledge from basic pharmacology regarding pharmacodynamics and pharmacokinetics into clinical practice.

Pharmacological Considerations

• Discussion includes how drugs are metabolized and excreted, highlighting considerations for patients with chronic kidney disease or those requiring prodrugs like enalapril. Understanding these processes is crucial for safe prescribing practices.

Open Communication Encouraged

• The speaker invites students to reach out if they have further questions or need clarification on any topics discussed during the session. This promotes an open line of communication between students and instructors for better learning outcomes.